Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-13 Snodgres Jon Chief Financial Officer Sale −1,612 $128.70 $207K 38,486
2020-05-13 Snodgres Jon Chief Financial Officer Sale −1,700 $130.20 $221K 36,786
2020-05-13 Snodgres Jon Chief Financial Officer Sale −3,013 $131.38 $396K 33,773
2020-05-13 Snodgres Jon Chief Financial Officer Sale −846 $132.37 $112K 32,927
2020-05-13 Snodgres Jon Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −3,170 0
2020-05-13 Snodgres Jon Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −9,024 3,086
2020-05-13 KURIYEL RALF Senior VP, R&D Exercise or conversion +6,000 $33.05 $198K 32,524
2020-05-13 KURIYEL RALF Senior VP, R&D Exercise or conversion +2,000 $33.87 $68K 34,524
2020-05-13 KURIYEL RALF Senior VP, R&D Sale −1,612 $126.88 $205K 32,912
2020-05-13 KURIYEL RALF Senior VP, R&D Sale −6,293 $128.02 $806K 26,619
2020-05-13 KURIYEL RALF Senior VP, R&D Sale −95 $128.55 $12K 26,524
2020-05-13 KURIYEL RALF Senior VP, R&D Exercise or conversion · Stock Option (Right to Buy) −6,000 4,000
2020-05-13 KURIYEL RALF Senior VP, R&D Exercise or conversion · Stock Option (Right to Buy) −2,000 10,850
2020-04-22 BARTHELEMY NICOLAS Director Exercise or conversion +1,652 $42.07 $69K 5,725
2020-04-22 BARTHELEMY NICOLAS Director Sale −2,688 $109.99 $296K 3,037
2020-04-22 BARTHELEMY NICOLAS Director Exercise or conversion · Stock Option (Right to Buy) −1,652 0
2020-04-21 DAWES KAREN A Director Exercise or conversion +11,800 $3.30 $39K 120,834
2020-04-21 DAWES KAREN A Director Exercise or conversion · Stock Option (Right to Buy) −11,800 0
2020-04-21 DAWES KAREN A Director Exercise or conversion +11,800 $3.30 $39K 120,834
2020-04-21 DAWES KAREN A Director Exercise or conversion · Stock Option (Right to Buy) −11,800 0

Page 36 of 42 · 832 trades